Viagra might have its market share reduced soon. Research scientists in Australia have made a nasal spray that helps treat male impotence and it could possibly be available to American buyers within two years.
Viagra is usually the go-to medicine when it comes to treating erectile dysfunction. However, it can take anywhere from 30 to 60 minutes for the drug to become active in the body.
The spray-to-play product reportedly works in as little as five minutes, meaning it could be a bedroom game-changer for the 30 million Americans who struggle to gain and maintain an erection.
“Our nasal delivery bypasses the digestive system, so it really goes straight into the bloodstream and has an effect in five to 15 minutes,” Lee Rodne, executive chairman of biotech company LTR Pharma, told the Australian on Monday.
“We expect it to be a lot more effective than oral tablets so that it works consistently and in a quicker and faster amount of time, so men don’t have to plan ahead and they don’t have variable results,” he enthusiastically added.
The new spray, SPONTAN, will soon be featured in a clinical trial to compare its overall results the oral options such as Viagra and Cialis
LTR Pharma has “very high confidence” SPONTAN will hit the US market in 2025.
In addition to SPONTAN, there may be another strong competitor for Viagra in the near future.
In 2022, a saucy study found that penile injections of Botox can provide “a clear benefit” for men suffering from erectile dysfunction.
